Brian Nowosielski

Health care economist Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed the potential impact pharmaceutical tariffs may have on access to generic and brand-name drugs.

Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed her ongoing research regarding the potential impact of pharmaceutical tariffs on the prescription drug market.

In a world where drug shortages are one of the most pressing issues for pharmacy businesses, there are certain tools making a significant difference in helping patients access their drugs at the pharmacy.

Currently under development, the manufacturer’s investigational pandemic influenza vaccine is designed to target the H5 avian influenza virus, or bird flu.

Alecia Lashier, chief automation officer and executive vice president at iA, discusses transformations in the pharmacy industry and how they’ve impacted pharmacists and their businesses.

Researchers evaluated PBM reimbursement practices in Medicare and whether they resulted in out-of-pocket cost increases for Part D beneficiaries.

Researchers conducted a scoping review to evaluate conversational AI agents and their use in pharmacy education.

Researchers aimed to estimate the impact of using behavioral science principles within communication intended for hypertension medication adherence.

Researchers explored how relationships between physicians, pharmacists, and patients are associated with the use of generic drugs in Japanese pharmacies.

David Swenson, RPh, discussed drug shortage technology that his company is helping bring to community pharmacies across the country.

PBM expert Antonio Ciaccia, president of 3 Axis Advisors and CEO of 46brooklyn Research, discussed recent events in the pharmacy benefits industry and how it is moving toward PBM reform.

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discussed his role in uncovering PBM practices and pharmacy consulting.

Researchers explored the current evidence regarding women’s reactions to biological therapies for treating atopic dermatitis during pregnancy.

David Swenson, RPh, Founder and CEO of ShortStop Rx, joined Drug Topics to discuss the CCT Rx Shortage Solutions technology and how it’s helping combat drug shortages in the US.

Approval comes from positive results in the MATINEE and METREX phase III trials, with data showing a significant reduction in annual rates of COPD exacerbations among patients.

Insulin delivery technology company Sequel Med Tech announced its future partnership with Abbott’s glucose-ketone sensor, which is currently under development.

During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.

Through a comprehensive review and meta-analysis, researchers identified the correlation between atopic dermatitis and dementia.

Researchers investigate annual medication costs for children and determine which of them would qualify for medication therapy management based on CMS thresholds.

Researchers aim to understand how deprescribing interventions impacted changes in inappropriate medication use or total prescription drugs among older, community-dwelling adults.

President of the National Foundation for Infectious Diseases, Jeff Goad, PharmD, MPH, discusses how pharmacists can help improve hepatitis A and B vaccine rates across the country.

In part 2 of our video series with drug market experts Luke Turnock, PhD, and Jenny Markell, we explored social media advertisements for prescription drugs and how they may impact patients.

Researchers estimate the cost-effectiveness of PCV24 in the older adult population compared with the currently accepted pneumococcal vaccine schedules in the US.

Researchers wanted to better understand prescribing patterns of pneumococcal vaccines for people living with HIV in a tertiary care hospital.

Researchers conduct a scoping review to update and determine what the best available options are for treating patients with skin-picking disorder.

In children aged 5 to 17 with skin disorders, researchers explore the risk of developing psychosocial comorbidities, sleep disturbances, and common related symptoms.

Jeff Goad, PharmD, MPH, discusses hesitancy for hepatitis vaccines and the necessary advice pharmacists can utilize to help patients manage these misconceptions.

Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.

Drug Market experts joined Drug Topics to discuss the rise in direct-to-consumer drug advertising and what it means for patients around the world.

Jeff Goad, PharmD, MPH, discusses hepatitis viruses and the current vaccination schedules available for patients to stay protected.